$350,000 of MADRIGAL PHARMACEUTICALS INC. lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to CMMI drug pricing; 340B drug pricing Most Favored Nation drug pricing; Issues related to CMMI drug pricing"
You can find more data on corporate lobbying on Quiver Quantitative.
MDGL Insider Trading Activity
MDGL insiders have traded $MDGL stock on the open market 49 times in the past 6 months. Of those trades, 0 have been purchases and 49 have been sales.
Here’s a breakdown of recent trading of $MDGL stock by insiders over the last 6 months:
- WILLIAM JOHN SIBOLD (President and CEO) has made 0 purchases and 34 sales selling 14,083 shares for an estimated $7,607,451.
- RICHARD S LEVY has made 0 purchases and 12 sales selling 5,682 shares for an estimated $2,928,716.
- DAVID SOERGEL (Chief Medical Officer) has made 0 purchases and 2 sales selling 1,886 shares for an estimated $951,980.
- SHANNON T KELLEY (General Counsel) sold 664 shares for an estimated $341,940
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
MDGL Hedge Fund Activity
We have seen 210 institutional investors add shares of MDGL stock to their portfolio, and 170 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 359,195 shares (-23.0%) from their portfolio in Q2 2026, for an estimated $192,869,755
- UBS GROUP AG added 283,929 shares (+241.1%) to their portfolio in Q2 2026, for an estimated $152,455,676
- ADAGE CAPITAL PARTNERS GP, L.L.C. removed 185,331 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $99,513,480
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 184,324 shares (+inf%) to their portfolio in Q2 2026, for an estimated $98,972,771
- JANE STREET GROUP, LLC added 155,703 shares (+434.5%) to their portfolio in Q2 2026, for an estimated $83,604,725
- FMR LLC removed 155,527 shares (-30.4%) from their portfolio in Q2 2026, for an estimated $83,510,222
- HOLOCENE ADVISORS, LP added 152,924 shares (+inf%) to their portfolio in Q2 2026, for an estimated $82,112,541
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
MDGL Price Targets
Multiple analysts have issued price targets for $MDGL recently. We have seen 5 analysts offer price targets for $MDGL in the last 6 months, with a median target of $620.0.
Here are some recent targets:
- Alexandria Hammond from B of A Securities set a target price of $542.0 on 06/11/2026
- Srikripa Devarakonda from Truist Securities set a target price of $709.0 on 05/13/2026
- Liisa Bayko from Evercore ISI Group set a target price of $649.0 on 05/07/2026
- Edward Nash from Canaccord Genuity set a target price of $578.0 on 05/07/2026
- Andrew S. Fein from HC Wainwright & Co. set a target price of $620.0 on 05/06/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
